HK124595A - Anthocyanidins for the treatment of ophthalmic diseases - Google Patents

Anthocyanidins for the treatment of ophthalmic diseases

Info

Publication number
HK124595A
HK124595A HK124595A HK124595A HK124595A HK 124595 A HK124595 A HK 124595A HK 124595 A HK124595 A HK 124595A HK 124595 A HK124595 A HK 124595A HK 124595 A HK124595 A HK 124595A
Authority
HK
Hong Kong
Prior art keywords
anthocyanidins
delphidin
pelargonidin
treatment
subject
Prior art date
Application number
HK124595A
Other languages
English (en)
Inventor
Maria Jose Magistretti
Marisa Conti
Giorgio Pifferi
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Publication of HK124595A publication Critical patent/HK124595A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
HK124595A 1989-07-28 1995-08-03 Anthocyanidins for the treatment of ophthalmic diseases HK124595A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917323A GB8917323D0 (en) 1989-07-28 1989-07-28 Methods and pharmaceutical compositions for the treatment of ophthalmic diseases

Publications (1)

Publication Number Publication Date
HK124595A true HK124595A (en) 1995-08-11

Family

ID=10660801

Family Applications (1)

Application Number Title Priority Date Filing Date
HK124595A HK124595A (en) 1989-07-28 1995-08-03 Anthocyanidins for the treatment of ophthalmic diseases

Country Status (11)

Country Link
US (1) US5196449A (ja)
EP (1) EP0410749B1 (ja)
JP (1) JP2967523B2 (ja)
KR (1) KR0149026B1 (ja)
AT (1) ATE112960T1 (ja)
DE (1) DE69013431T2 (ja)
DK (1) DK0410749T3 (ja)
GB (1) GB8917323D0 (ja)
HK (1) HK124595A (ja)
IT (1) IT1245717B (ja)
PT (1) PT94848A (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
JP3414446B2 (ja) * 1993-07-23 2003-06-09 財団法人相模中央化学研究所 ヒドロキシシリル基を末端に有するポリオキシエチレン化合物、四級塩を末端に有するブロック共重合体、および経皮吸収促進剤
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
CA2373825C (en) 1999-07-02 2010-01-05 Meiji Seika Kaisha, Ltd. Anthocyanin-containing compositions for foods and drinks and process for producing the same
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
JP4593474B2 (ja) 2003-10-30 2010-12-08 明治製菓株式会社 チロシナーゼ活性阻害剤及び顔面血流改善剤
JP4873904B2 (ja) * 2005-08-22 2012-02-08 国立大学法人弘前大学 眼血管血流障害改善剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)
JP2013163669A (ja) * 2012-01-12 2013-08-22 Oriza Yuka Kk 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
FR2378272A1 (fr) * 1977-01-25 1978-08-18 Ferodo Sa Dispositif dynamometrique de mesure de couple pour engin a fleche de levage a commande par verin
BE864450R (fr) * 1978-03-01 1978-07-03 Inverni Della Beffa Spa Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
JPS55111418A (en) * 1979-02-21 1980-08-28 Santen Pharmaceut Co Ltd Remedy for eye disease and its preparation
EP0258476B1 (en) * 1986-09-02 1990-04-25 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2

Also Published As

Publication number Publication date
IT9020968A0 (it) 1990-07-18
EP0410749B1 (en) 1994-10-19
US5196449A (en) 1993-03-23
GB8917323D0 (en) 1989-09-13
JP2967523B2 (ja) 1999-10-25
KR910002442A (ko) 1991-02-25
EP0410749A3 (en) 1993-02-03
DE69013431D1 (de) 1994-11-24
EP0410749A2 (en) 1991-01-30
KR0149026B1 (ko) 1998-10-15
DK0410749T3 (da) 1994-11-14
PT94848A (pt) 1991-04-18
IT1245717B (it) 1994-10-14
JPH0381220A (ja) 1991-04-05
ATE112960T1 (de) 1994-11-15
DE69013431T2 (de) 1995-02-23
IT9020968A1 (it) 1992-01-18

Similar Documents

Publication Publication Date Title
AU549481B2 (en) Hair growing agent
HU883981D0 (en) Process for the production of medical preparations with antiviral or antibacterial effect
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
EP0430045A3 (en) Ascorbic acid tocopheryl phosphate diesters for inhibition of maillard's reaction
US3888977A (en) Modified neurotoxin
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
TW362973B (en) Use of 2-anino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a composition having an antidepressant activity
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
AU693833B2 (en) Products containing G-CSF and TNF binding protein
EP0410749A3 (en) Anthocyanidins for the treatment of ophthalmic diseases
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
HU911272D0 (en) Process for the production of medical preparations containing hexetidine
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
GR3017672T3 (en) Therapeutic agent for diabetic gangrene.
GR3001565T3 (en) Medical preparation comprising aspoxicillin, a method for its preparation, and the use of such a preparation for the manufacture of a medicament
KR890001555A (ko) 요산 배설용 조성물
AU1966988A (en) Ophthalmic agent and related compositions and method for treatment of the cornea
RU94024966A (ru) Средство для улучшения процессов микроциркуляции и коррекции иммуногемостатических нарушений при лечении глазных заболеваний
BG96092A (bg) Тиенотиопиранови сулфонамидни производни и приложението им в офталмологични препарати
RU99103787A (ru) Способ лечения у детей болезни шойермана-мау
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)